Brief: Vor Biopharma Says On Dec 9, 2022, Co Notified Jefferies LLC Of Its Decision To Terminate The Open Market Sale Agreementsm, Dated As Of March 14, 2022
14/12/2022 21:39
Dec 14 (Reuters) - Vor Biopharma Inc VOR.O :
* VOR BIOPHARMA - ON DEC 9, 2022, CO NOTIFIED JEFFERIES LLC
OF ITS
DECISION TO TERMINATE THE OPEN MARKET SALE AGREEMENTSM, DATED AS
OF MARCH 14, 2022
* VOR BIOPHARMA INC - THROUGH TERMINATION DATE, CO SOLD
AGGREGATE
OF 856,030 SHARES OF COMMON STOCK UNDER SALES AGREEMENT FOR NET
PROCEEDS OF $4.3 MILLION
Further company coverage: VOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vor Biopharma
See all newsBrief: Telitacicept Demonstrates Durable Preservation Of Kidney Function Through Two Years In Phase 3 Teligan Trial In Iga Nephropathy
Vor Bio says its experimental drug slowed loss of kidney function in late-stage study
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning